Legend Biotech (LEGN) Current Leases: 2019-2025
Historic Current Leases for Legend Biotech (LEGN) over the last 5 years, with Sep 2025 value amounting to $7.4 million.
- Legend Biotech's Current Leases rose 69.83% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 69.83%. This contributed to the annual value of $4.8 million for FY2024, which is 50.99% up from last year.
- As of Q3 2025, Legend Biotech's Current Leases stood at $7.4 million, which was up 24.86% from $5.9 million recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Current Leases ranged from a high of $7.4 million in Q3 2025 and a low of $1,673 during Q1 2021.
- Moreover, its 3-year median value for Current Leases was $4.3 million (2024), whereas its average is $4.4 million.
- As far as peak fluctuations go, Legend Biotech's Current Leases tumbled by 37.77% in 2021, and later surged by 218,070.95% in 2022.
- Legend Biotech's Current Leases (Quarterly) stood at $911,000 in 2021, then soared by 291.11% to $3.6 million in 2022, then declined by 10.89% to $3.2 million in 2023, then soared by 50.99% to $4.8 million in 2024, then skyrocketed by 69.83% to $7.4 million in 2025.
- Its Current Leases was $7.4 million in Q3 2025, compared to $5.9 million in Q2 2025 and $5.3 million in Q1 2025.